Commerzbank Turns To Profit In Q1 - Quick Facts

Commerzbank AG (CRZBY.PK) reported that its first-quarter consolidated profit attributable to shareholders was 133 million euros compared to a loss of 291 million euros in the prior year.

Total operating profit was 538 million euros compared to an operating loss of 278 million euros in the prior year. It more than compensated for the restructuring charges of 465 million euros booked in the first quarter.

Revenues for the first quarter increased 35% to 2.49 billion euros from last year, primarily on the basis of a strong net commission income and positive valuation effects. The underlying revenues, excluding exceptional items, rose to 2.31 billion euros from 2.02 billion euros in the prior year.

Commerzbank had already agreed a voluntary redundancy program on a headcount reduction of 1,700 full-time equivalents for 2021.

The company said revenues should slightly exceed the previous year. While uncertainty of the further development of the pandemic remains, a risk result in the range from minus 0.8 billion euros to minus 1.2 billion euros is anticipated. Based on current observations, a risk result up to minus 1 billion euros is likely.

Commerzbank expects a positive operating result. The expectations are based on the assumption that there is no fundamental change affecting the Swiss francs loan portfolio at mBank.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The 737 MAX 10, Boeing Co.'s largest 737 Max model, is taking its maiden flight today, reports said citing people familiar with the matter. The flight after months of testing and certification will be around 10 a.m. local time from the Seattle area. The schedule could change depending on weather or other factors. Meanwhile, the jetliner is expected to enter commercial service in 2023. Medical devices supplier Smiths Medical, affiliated to Smiths Group plc, is recalling certain Jelco Hypodermic Needle-Pro Fixed Needle insulin syringes with skewed graduation markings, the U.S. Food and Drug Administration said. The recall was initiated after the company became aware of specific models and lots of Jelco insulin syringes that may exhibit skewed odd number line graduation markings. Saliva-based COVID-19 testing is rolled out as a pilot for public schools in New York City. The new two-month pilot program is being implemented in about 50 New York City public schools and utilizes Fluidigm Technology to offer RT-PCR COVID-19 testing. New York City public schools have instituted mandatory random weekly testing in all reopened school buildings to ensure safer in-person learning.
Follow RTT